$2M sweet spot round size
Most of their 22 investments are in rounds between $400K and $3M
2002
Gate Neurosciences, Inc. raised $25M on October 5, 2022
Investors: Thornapple River Capital, Innoviva and BioCrossroads
Lumavate raised $6M on January 31, 2022
Investors: Gutbrain Ventures, Allos Ventures and BioCrossroads
Kovina Therapeutics raised $2M on October 20, 2021
Investors: Elevate Ventures, Indiana University Research and Technology Corporation and BioCrossroads
Novosteo Inc raised $5.5M on January 13, 2021
Investors: Elevate Ventures, Purdue Research Foundation, Kairos Ventures and BioCrossroads
Sabanto raised $3M on December 24, 2020
Investors: DCVC Bio, Cavallo Ventures and BioCrossroads
MBX Biosciences, Inc. raised $35M on July 27, 2020
Investors: OrbiMed Advisors, Frazier Healthcare Partners, Indiana Philanthropic Venture Fund (IU PhV) and BioCrossroads
Undisclosed raised $5M on September 24, 2019
Investors: Cook Regentec, Casdin Capital, LLC, BioLife Solutions and BioCrossroads
Sabanto raised $2M on August 12, 2019
Investors: DCVC Bio and BioCrossroads
Lumavate raised $3M on June 12, 2019
Investors: Elevate Ventures and BioCrossroads
Scioto Biosciences, Inc raised $1.8M on May 21, 2018
Investors: Pathway Bioventures, Rev1 Ventures, Elevate Ventures and BioCrossroads
$1.5M
from 1 investors over 1 rounds
BioCrossroads raised $1.5M on December 4, 2018
Investors: Richard M. Fairbanks Foundation